{"id":9022,"date":"2025-08-11T11:30:00","date_gmt":"2025-08-11T15:30:00","guid":{"rendered":"https:\/\/stillcoviding.ca\/en\/?p=9022"},"modified":"2025-08-12T22:10:18","modified_gmt":"2025-08-13T02:10:18","slug":"lab-made-sugar-coated-particle-blocks-covid-19-infection-possible-new-treatment-on-the-horizon","status":"publish","type":"post","link":"https:\/\/stillcoviding.ca\/en\/news\/lab-made-sugar-coated-particle-blocks-covid-19-infection-possible-new-treatment-on-the-horizon\/","title":{"rendered":"Lab-made sugar-coated particle blocks Covid-19 infection \u2014 Possible new treatment on the horizon"},"content":{"rendered":"<p>Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem \u2014 a sugar-coated polymer nanoparticle \u2014 that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.<\/p>\n<p>The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid \u2014 structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus\u2019s spike protein and preventing it from attaching to real cells.<\/p>\n<p>Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.<\/p>\n<p>Using advanced lab techniques to measure molecular interactions and simulate virus binding, researchers found that the glycosystem binds to the virus <strong>500 times more strongly<\/strong> than a similar compound containing sulphates but no sugars. It was also effective at very low doses and worked against both the original SARS-CoV-2 strain and the more infectious D614G variant.<\/p>\n<p>Tests on human lung cells showed a <strong>98.6% reduction in infection<\/strong> when the molecule was present. Crucially, the research highlighted that its effectiveness stems not just from its charge, but from its precise sugar structure \u2014 giving this glycosystem its powerful infection-blocking capability.<\/p>\n<p><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/smll.202500719\" target=\"_blank\" lang=\"en\" rel=\"noreferrer noopener\">The discovery<\/a> is the result of collaboration between Swansea University, <a href=\"https:\/\/www.fu-berlin.de\/\" target=\"_blank\" lang=\"de\" rel=\"noreferrer noopener\">Freie Universit\u00e4t Berlin<\/a>, and <a href=\"https:\/\/virologie-ccm.charite.de\/en\/\" target=\"_blank\" lang=\"en\" rel=\"noreferrer noopener\">Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem \u2014 a sugar-coated polymer nanoparticle \u2014 that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.<\/p>\n<p>The glycosystem is a specially designed particle that mimics natural sugars found on human cells. These sugars, known as polysialosides, are made of repeating units of sialic acid \u2014 structures that viruses often target to begin infection. By copying this structure, the synthetic molecule acts as a decoy, binding to the virus\u2019s spike protein and preventing it from attaching to real cells.<\/p>\n<p>Unlike vaccines, which trigger immune responses, this molecule acts as a physical shield, offering a novel approach to infection prevention.<\/p>\n<div class=\"more-link-wrapper\"><a class=\"more-link\" href=\"https:\/\/stillcoviding.ca\/en\/news\/lab-made-sugar-coated-particle-blocks-covid-19-infection-possible-new-treatment-on-the-horizon\/\">Continue reading<span class=\"screen-reader-text\">Lab-made sugar-coated particle blocks Covid-19 infection \u2014 Possible new treatment on the horizon<\/span><\/a><\/div>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[1358,18,334,1357,397,88,1356,8,14,1355,50],"class_list":["post-9022","post","type-post","status-publish","format-standard","hentry","category-news","tag-charite-universitatsmedizin-berlin","tag-covid-19","tag-european-union","tag-freie-universitat-berlin","tag-germany","tag-medical-treatments","tag-prifysgol-abertawe","tag-research","tag-sars-cov-2","tag-swansea-university","tag-united-kingdom","entry"],"_links":{"self":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/9022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/comments?post=9022"}],"version-history":[{"count":2,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/9022\/revisions"}],"predecessor-version":[{"id":9025,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/posts\/9022\/revisions\/9025"}],"wp:attachment":[{"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/media?parent=9022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/categories?post=9022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stillcoviding.ca\/en\/wp-json\/wp\/v2\/tags?post=9022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}